Published in EMBO J on June 03, 1996
Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line. Mol Cell Biol (1997) 4.12
Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol Cell Biol (1997) 3.34
Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG. Genes Dev (1998) 3.00
B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1. J Exp Med (2012) 1.65
Concerted activity of host cell factor subregions in promoting stable VP16 complex assembly and preventing interference by the acidic activation domain. Mol Cell Biol (1997) 1.51
c-Maf interacts with c-Myb to regulate transcription of an early myeloid gene during differentiation. Mol Cell Biol (1998) 1.25
Regulation of BOB.1/OBF.1 stability by SIAH. EMBO J (2001) 1.23
POU domain transcription factor brain 4 confers pancreatic alpha-cell-specific expression of the proglucagon gene through interaction with a novel proximal promoter G1 element. Mol Cell Biol (1997) 1.18
Linker length and composition influence the flexibility of Oct-1 DNA binding. EMBO J (1997) 1.17
Crystal structure of an OCA-B peptide bound to an Oct-1 POU domain/octamer DNA complex: specific recognition of a protein-DNA interface. Genes Dev (1999) 1.15
OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain. Mol Cell Biol (1997) 1.15
The RING finger protein Siah-1 regulates the level of the transcriptional coactivator OBF-1. EMBO J (2001) 1.13
STAT5 and Oct-1 form a stable complex that modulates cyclin D1 expression. Mol Cell Biol (2003) 1.12
Coactivator OBF-1 makes selective contacts with both the POU-specific domain and the POU homeodomain and acts as a molecular clamp on DNA. Mol Cell Biol (1998) 1.12
Chromatin remodeling of the interleukin-2 gene: distinct alterations in the proximal versus distal enhancer regions. Nucleic Acids Res (1998) 1.12
Recruitment of octamer transcription factors to DNA by glucocorticoid receptor. Mol Cell Biol (1998) 1.06
Direct interactions of OCA-B and TFII-I regulate immunoglobulin heavy-chain gene transcription by facilitating enhancer-promoter communication. Mol Cell (2011) 1.04
Distinct regulatory mechanism of immunoglobulin gene transcription in epithelial cancer cells. Cell Mol Immunol (2010) 1.02
Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas. Am J Pathol (2000) 1.01
BOB.1/OBF.1 deficiency affects marginal-zone B-cell compartment. Mol Cell Biol (2002) 1.01
Activation of enhancer elements by the homeobox gene Cdx2 is cell line specific. Nucleic Acids Res (1997) 1.01
Differential in vivo activation of the class II and class III snRNA genes by the POU-specific domain of Oct-1. Nucleic Acids Res (1997) 0.98
Oct-1 potentiates CREB-driven cyclin D1 promoter activation via a phospho-CREB- and CREB binding protein-independent mechanism. Mol Cell Biol (2002) 0.98
The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development. Mol Cell Biol (2001) 0.98
Coactivation by OCA-B: definition of critical regions and synergism with general cofactors. Mol Cell Biol (1998) 0.97
OBF1 enhances transcriptional potential of Oct1. EMBO J (2003) 0.91
Sequence-specific DNA binding by the alphaNAC coactivator is required for potentiation of c-Jun-dependent transcription of the osteocalcin gene. Mol Cell Biol (2005) 0.91
A novel retinoic acid-responsive element regulates retinoic acid-induced BLR1 expression. Mol Cell Biol (2004) 0.90
Oct-2 regulates CD36 gene expression via a consensus octamer, which excludes the co-activator OBF-1. Nucleic Acids Res (2002) 0.88
Combinatorial binding of transcription factors in the pluripotency control regions of the genome. Genome Res (2011) 0.87
A conserved sequence block in murine and human T cell receptor (TCR) Jalpha region is a composite element that enhances TCR alpha enhancer activity and binds multiple nuclear factors. Proc Natl Acad Sci U S A (1998) 0.85
Octamer-dependent transcription in T cells is mediated by NFAT and NF-κB. Nucleic Acids Res (2013) 0.85
Identification of amino acid residues in the Caenorhabditis elegans POU protein UNC-86 that mediate UNC-86-MEC-3-DNA ternary complex formation. Mol Cell Biol (2000) 0.83
Btk expression is controlled by Oct and BOB.1/OBF.1. Nucleic Acids Res (2006) 0.83
Phosphorylation of Oct-2 at sites located in the POU domain induces differential down-regulation of Oct-2 DNA-binding ability. Biochem J (2000) 0.82
B-Cell coactivator OBF-1 exhibits unusual transcriptional properties and functions in a DNA-bound Oct-1-dependent fashion. Mol Cell Biol (1999) 0.81
Oct2 and Obf1 as Facilitators of B:T Cell Collaboration during a Humoral Immune Response. Front Immunol (2014) 0.81
Silencing and nuclear repositioning of the lambda5 gene locus at the pre-B cell stage requires Aiolos and OBF-1. PLoS One (2008) 0.80
Conservation and divergence of the Emicro3' enhancer in the IGH locus of teleosts. Immunogenetics (2006) 0.80
Redundant role of tissue-selective TAF(II)105 in B lymphocytes. Mol Cell Biol (2002) 0.80
A C-terminal acidic domain regulates degradation of the transcriptional coactivator Bob1. Mol Cell Biol (2013) 0.79
Cysteine 50 of the POU H domain determines the range of targets recognized by POU proteins. Nucleic Acids Res (1997) 0.76
Myosin light chain 1 atrial isoform (MLC1A) is expressed in pre-B cells under control of the BOB.1/OBF.1 coactivator. Nucleic Acids Res (2004) 0.76
Basic local alignment search tool. J Mol Biol (1990) 659.07
Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res (1992) 34.33
Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. Genes Dev (1988) 8.82
A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature (1986) 8.64
PHD--an automatic mail server for protein secondary structure prediction. Comput Appl Biosci (1994) 6.71
The Oct-1 homoeodomain directs formation of a multiprotein-DNA complex with the HSV transactivator VP16. Nature (1989) 5.43
Herpes simplex virus regulatory elements and the immunoglobulin octamer domain bind a common factor and are both targets for virion transactivation. Cell (1988) 5.18
A cloned octamer transcription factor stimulates transcription from lymphoid-specific promoters in non-B cells. Nature (1988) 5.16
The SV40 enhancer can be dissected into multiple segments, each with a different cell type specificity. Genes Dev (1987) 4.20
Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions. EMBO J (1992) 4.05
Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell (1994) 3.98
Interaction of a common factor with conserved promoter and enhancer sequences in histone H2B, immunoglobulin, and U2 small nuclear RNA (snRNA) genes. Proc Natl Acad Sci U S A (1986) 3.81
OVEC, a versatile system to study transcription in mammalian cells and cell-free extracts. Nucleic Acids Res (1987) 3.56
OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell (1995) 3.38
POU-domain transcription factors: pou-er-ful developmental regulators. Genes Dev (1991) 3.16
The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. Genes Dev (1995) 2.97
Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol Cell Biol (1995) 2.74
Multiple sequence elements are required for maximal in vitro transcription of a human histone H2B gene. Mol Cell Biol (1986) 2.69
A B-cell coactivator of octamer-binding transcription factors. Nature (1995) 2.67
Octamania: the POU factors in murine development. Trends Genet (1991) 2.55
High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. EMBO J (1995) 2.48
Cell-cycle regulation of a human histone H2b gene is mediated by the H2b subtype-specific consensus element. Genes Dev (1988) 2.47
A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors. Cell (1992) 2.43
Immunoglobulin gene transcription. Annu Rev Immunol (1991) 2.34
A single amino acid exchange transfers VP16-induced positive control from the Oct-1 to the Oct-2 homeo domain. Genes Dev (1992) 2.23
The herpes simplex virus trans-activator VP16 recognizes the Oct-1 homeo domain: evidence for a homeo domain recognition subdomain. Genes Dev (1991) 2.22
Recognition of the surface of a homeo domain protein. Genes Dev (1992) 1.85
Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes Dev (1993) 1.84
Activation of octamer-containing promoters by either octamer-binding transcription factor 1 (OTF-1) or OTF-2 and requirement of an additional B-cell-specific component for optimal transcription of immunoglobulin promoters. Mol Cell Biol (1990) 1.58
Site-specific conformational alteration of the Oct-1 POU domain-DNA complex as the basis for differential recognition by Vmw65 (VP16). Cell (1994) 1.57
The promoter of the human interleukin-2 gene contains two octamer-binding sites and is partially activated by the expression of Oct-2. Mol Cell Biol (1990) 1.49
Promoters with the octamer DNA motif (ATGCAAAT) can be ubiquitous or cell type-specific depending on binding affinity of the octamer site and Oct-factor concentration. Nucleic Acids Res (1991) 1.46
Structural requirements in the herpes simplex virus type 1 transactivator Vmw65 for interaction with the cellular octamer-binding protein and target TAATGARAT sequences. J Virol (1990) 1.46
Octamer transcription factors and the cell type-specificity of immunoglobulin gene expression. FASEB J (1990) 1.42
Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity. Mol Cell Biol (1992) 1.35
Complex pattern of immunoglobulin mu gene expression in normal and transgenic mice: nonoverlapping regulatory sequences govern distinct tissue specificities. Genes Dev (1991) 1.30
Mechanisms for flexibility in DNA sequence recognition and VP16-induced complex formation by the Oct-1 POU domain. Mol Cell Biol (1995) 1.25
Rapid test for in vivo stability and DNA binding of mutated octamer binding proteins with 'mini-extracts' prepared from transfected cells. Nucleic Acids Res (1989) 1.16
Interaction between the octamer-binding protein nuclear factor III and the adenovirus origin of DNA replication. J Virol (1988) 1.16
Two versatile eukaryotic vectors permitting epitope tagging, radiolabelling and nuclear localisation of expressed proteins. Gene (1996) 1.15
Functional characterization of elements in a human U6 small nuclear RNA gene distal control region. Mol Cell Biol (1993) 1.07
Positive and negative regulation at the herpes simplex virus ICP4 and ICP0 TAATGARAT motifs. Virology (1995) 1.02
Histone H2B gene transcription during Xenopus early development requires functional cooperation between proteins bound to the CCAAT and octamer motifs. Mol Cell Biol (1992) 0.98
Cell type- and stage-specific expression of the CD20/B1 antigen correlates with the activity of a diverged octamer DNA motif present in its promoter. J Biol Chem (1993) 0.96
Mutation of the Oct-1 POU-specific recognition helix leads to altered DNA binding and influences enhancement of adenovirus DNA replication. Nucleic Acids Res (1995) 0.88
POU-specific domain of Oct-2 factor confers 'octamer' motif DNA binding specificity on heterologous Antennapedia homeodomain. FEBS Lett (1992) 0.82
A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal Biochem (1973) 31.32
Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res (1989) 22.73
Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences. Cell (1981) 20.72
A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell (1983) 20.32
A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell (1985) 16.46
Novel screening procedure for recombinant plasmids. Science (1977) 12.66
A small segment of polyoma virus DNA enhances the expression of a cloned beta-globin gene over a distance of 1400 base pairs. Nucleic Acids Res (1981) 7.57
Psychotropic drug use and the risk of hip fracture. N Engl J Med (1987) 7.53
An outbreak of Legionnaires' disease associated with a contaminated air-conditioning cooling tower. N Engl J Med (1980) 6.64
Direct transfer of cloned genes from bacteria to mammalian cells. Proc Natl Acad Sci U S A (1980) 6.21
A lymphocyte-specific enhancer in the mouse immunoglobulin kappa gene. Nature (1984) 6.05
Molecular analysis of the histone gene cluster of psammechinus miliaris: II. The arrangement of the five histone-coding and spacer sequences. Cell (1976) 5.58
Mass psychogenic illness attributed to toxic exposure at a high school. N Engl J Med (2000) 5.25
Genes and spacers of cloned sea urchin histone DNA analyzed by sequencing. Cell (1978) 5.18
A cloned octamer transcription factor stimulates transcription from lymphoid-specific promoters in non-B cells. Nature (1988) 5.16
CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev (1989) 5.00
Innovative communicable disease reporting. HSMHA Health Rep (1971) 4.67
Cell type-specificity elements of the immunoglobulin heavy chain gene enhancer. EMBO J (1987) 4.58
Polyoma virus DNA replication requires an enhancer. Nature (1984) 4.32
Immunization of adults. N Engl J Med (1993) 4.23
The SV40 enhancer can be dissected into multiple segments, each with a different cell type specificity. Genes Dev (1987) 4.20
Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions. EMBO J (1992) 4.05
Transcriptional 'enhancers' from SV40 and polyoma virus show a cell type preference. Nucleic Acids Res (1982) 3.94
Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science (1994) 3.92
An SV40 "enhancer trap" incorporates exogenous enhancers or generates enhancers from its own sequences. Cell (1984) 3.61
OVEC, a versatile system to study transcription in mammalian cells and cell-free extracts. Nucleic Acids Res (1987) 3.56
A surgeon with AIDS. Lack of evidence of transmission to patients. JAMA (1990) 3.49
Identification of a novel lymphoid specific octamer binding protein (OTF-2B) by proteolytic clipping bandshift assay (PCBA). EMBO J (1988) 3.33
Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. Genes Dev (1988) 3.05
Overwhelming strongyloidiasis: an unappreciated opportunistic infection. Medicine (Baltimore) (1978) 2.98
RNA polymerase II C-terminal domain required for enhancer-driven transcription. Nature (1995) 2.78
A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. Proc Natl Acad Sci U S A (1985) 2.74
Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) (1985) 2.67
A B-cell coactivator of octamer-binding transcription factors. Nature (1995) 2.67
Letter: Adenovirus type 19 keratoconjunctivitis. N Engl J Med (1974) 2.63
Transmission of tuberculosis in a jail. Ann Intern Med (1999) 2.58
Risk of seizures and encephalopathy after immunization with the diphtheria-tetanus-pertussis vaccine. JAMA (1990) 2.54
Molecular genetic analyses of the Tyrolean Ice Man. Science (1994) 2.53
Improving antibiotic prescribing in office practice. A controlled trial of three educational methods. JAMA (1983) 2.50
Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA (2001) 2.40
Transformation of frog embryos with a rabbit beta-globin gene. Proc Natl Acad Sci U S A (1981) 2.37
Transcriptional repression by RING finger protein TIF1 beta that interacts with the KRAB repressor domain of KOX1. Nucleic Acids Res (1996) 2.35
The conserved CAAGAAAGA spacer sequence is an essential element for the formation of 3' termini of the sea urchin H3 histone mRNA by RNA processing. EMBO J (1985) 2.34
Cloned transcription factor MTF-1 activates the mouse metallothionein I promoter. EMBO J (1993) 2.30
An enhancer stimulates transcription in trans when attached to the promoter via a protein bridge. Cell (1989) 2.30
Metal binding 'finger' structures in the glucocorticoid receptor defined by site-directed mutagenesis. EMBO J (1988) 2.26
Cell-type preference of immunoglobulin kappa and lambda gene promoters. EMBO J (1985) 2.22
Clinical epidemiology of sporadic measles in a highly immunized population. N Engl J Med (1968) 2.22
The transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein gene expression. EMBO J (1994) 2.19
Eukaryotic expression vectors for the analysis of mutant proteins. Nucleic Acids Res (1989) 2.15
Correct transcription of a cloned mouse immunoglobulin gene in vivo. Proc Natl Acad Sci U S A (1983) 2.14
High frequency of homologous recombination in mammalian cells between endogenous and introduced SV40 genomes. Cell (1985) 2.14
Evolution of a plasmid mediating resistance to multiple antimicrobial agents during a prolonged epidemic of nosocomial infections. J Infect Dis (1981) 2.13
Seroepidemiology of hepatitis B in Tennessee prisoners. J Infect Dis (1984) 2.12
A zinc-responsive factor interacts with a metal-regulated enhancer element (MRE) of the mouse metallothionein-I gene. EMBO J (1988) 2.10
DNA phylogeny of the extinct marsupial wolf. Nature (1989) 2.07
Molecular analysis of the histone gene cluster of Psammechinus miliaris: III. Polarity and asymmetry of the histone-coding sequences. Cell (1976) 2.07
The incidence of hepatitis B in Tennessee prisoners. J Infect Dis (1985) 2.00
Analysis of the transcriptional enhancer effect. Cold Spring Harb Symp Quant Biol (1983) 1.99
Integration of eukaryotic genes for 5S RNA and histone proteins into a phage lambda receptor. Nucleic Acids Res (1976) 1.99
A novel expression assay to study transcriptional activators. Gene (1990) 1.96
An outbreak of nosocomial infection due to multiply resistant Serratia marcescens: evidence of interhospital spread. J Infect Dis (1976) 1.95
Amino-terminal domain of NF1 binds to DNA as a dimer and activates adenovirus DNA replication. EMBO J (1990) 1.95
A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse. Am J Public Health (1980) 1.94
Molecular analysis of the histone gene cluster of Psammechinus miliaris: I. Fractionation and identification of five individual histone mRNAs. Cell (1976) 1.93
The use and efficacy of child restraint devices. The Tennessee experience, 1982 and 1983. JAMA (1984) 1.90
Mitochondrial DNA sequences from Switzerland reveal striking homogeneity of European populations. Biol Chem Hoppe Seyler (1994) 1.87
Sporadic cases of Legionnaires' disease: the expanding clinical spectrum. Ann Intern Med (1979) 1.85
Enhancer sequences and the regulation of gene transcription. Eur J Biochem (1988) 1.84
How do different transcription factors binding the same DNA sequence sort out their jobs? Trends Genet (1989) 1.83
A novel expression selection approach allows precise mapping of the hepatitis B virus enhancer. Nucleic Acids Res (1985) 1.82
Miniature chest radiograph screening for tuberculosis in jails: a cost-effectiveness analysis. Am J Respir Crit Care Med (2001) 1.81
Processing and nucleo-cytoplasmic transport of histone gene transcripts. Nucleic Acids Res (1984) 1.80
Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis (1994) 1.78
Salmonella enteritidis gastroenteritis transmitted by intact chicken eggs. Ann Intern Med (1991) 1.77
Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies. Yale J Biol Med (1967) 1.75
Therapeutic and epidemiologic recommendations to reduce the spread of type-I beta-lactamase resistance. Diagn Microbiol Infect Dis (1992) 1.74
An embryonic demethylation mechanism involving binding of transcription factors to replicating DNA. EMBO J (1998) 1.74
Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis (1983) 1.72
Ehrlichiosis in a golf-oriented retirement community. N Engl J Med (1995) 1.71
Octamer transcription factors bind to two different sequence motifs of the immunoglobulin heavy chain promoter. EMBO J (1989) 1.70
Mutagenesis and selection of PDZ domains that bind new protein targets. Nat Biotechnol (1999) 1.69
A purine-rich DNA sequence motif present in SV40 and lymphotropic papovavirus binds a lymphoid-specific factor and contributes to enhancer activity in lymphoid cells. Genes Dev (1987) 1.68
Reduction in motor vehicle fatalities associated with an increase in the minimum drinking age. JAMA (1989) 1.68
Simian virus 40 enhancer increases RNA polymerase density within the linked gene. Nature (1985) 1.66
Rhodococcus equi--an increasingly recognized opportunistic pathogen. Report of 12 cases and review of 65 cases in the literature. Am J Clin Pathol (1995) 1.66
Homologous recombination and DNA-end joining reactions in zygotes and early embryos of zebrafish (Danio rerio) and Drosophila melanogaster. Biol Chem (1998) 1.65
Carriage of multidrug-resistant Streptococcus pneumoniae and impact of chemoprophylaxis during an outbreak of meningitis at a day care center. Clin Infect Dis (1999) 1.64
Embryonic lethality and liver degeneration in mice lacking the metal-responsive transcriptional activator MTF-1. EMBO J (1998) 1.61